Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study von Reardon, D A, Desjardins, A, Vredenburgh, J J, Gururangan, S, Sampson, J H, Sathornsumetee, S, McLendon, R E, Herndon, J E, Marcello, J E, Norfleet, J, Friedman, A H, Bigner, D D, Friedman, H S

Volltext

Analysis of graph invariants in functional neocortical circuitry reveals generalized features common to three areas of sensory cortex von Gururangan, Suchin S, Sadovsky, Alexander J, MacLean, Jason N

Volltext

Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study von Gururangan, Sridharan, Fangusaro, Jason, Young Poussaint, Tina, Onar-Thomas, Arzu, Gilbertson, Richard J, Vajapeyam, Sridhar, Gajjar, Amar, Goldman, Stewart, Friedman, Henry S, Packer, Roger J, Boyett, James M, Kun, Larry E, McLendon, Roger

Volltext

Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy von Flores, C, Wildes, T, Dean, B DiVita, Moore, G, Drake, J, Abraham, R, Gil, J, Yegorov, O, Yang, C, Dean, J, Moneypenny, C, Shin, D, Pham, C, Krauser, J, King, J, Grant, G, Driscoll, T, Kurtzberg, J, McLendon, R, Gururangan, S, Mitchell, D

Volltext

Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations von López, G. Y., Grant, G. A., Fuchs, H. E., Leithe, L. G., Gururangan, S., Bigner, D. D., Yan, H., McLendon, R. E., He, Y.

Volltext

Central Nervous System Extraosseous Ewing Sarcoma: Radiologic Manifestations of This Newly Defined Pathologic Entity von Pekala, J.S, Gururangan, S, Provenzale, J.M, Mukundan, S., Jr

Volltext

Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B von WALKER, J. A., DIXON, N., GURURANGAN, S., THORNBURG, C.

Volltext

Molecular variants and mutations in medulloblastoma von Schroeder, Kristin, Gururangan, Sri

Volltext

Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM) von Friedman, H. S., Desjardins, A., Vredenburgh, J. J., Rich, J. N., Sathornsumetee, S., Gururangan, S., Quinn, J. A., Reardon, D. A.

Volltext

Combination of bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and temozolomide: Study of cases von Kirkpatrick, J., Desjardins, A., Vredenburgh, J. J., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Friedman, A. H., Friedman, H. S., Reardon, D. A.

Volltext

Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma von REARDON, David A, QUINN, Jennifer A, PROVENZALE, James M, SAMPSON, John H, SMITH, Robert P, SWAISLAND, Alan J, OCHS, Judith S, LYONS, Peggy, TOURT-UHLIG, Sandy, BIGNER, Darell D, FRIEDMAN, Henry S, RICH, Jeremy N, VREDENBURGH, James J, GURURANGAN, Sridharan, FRIEDMAN, Allan H, DESJARDINS, Annick, SATHORNSUMETEE, Sith, HERNDON, James E, DOWELL, Jeannette M, MCLENDON, Roger E

Volltext

Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer von MULHERN, Raymond K, KHAN, Raja B, REDDICK, Wilburn E, KAPLAN, Stuart, HELTON, Susan, CHRISTENSEN, Robbin, BONNER, Melanie, BROWN, Ronald, XIAOPING XIONG, SENGJIE WU, GURURANGAN, Sridharan

Volltext

Prognostic value of medulloblastoma surgical cytoreduction after accounting for molecular subgroup von Thompson, E M, Hielscher, T, Bouffet, E, Remke, M, Luu, B, Gururangan, S, Grotzer, M A, Shalaby, T

Volltext

Phase I Trial of Temozolomide Plus O 6 -Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma von Quinn, Jennifer A., Desjardins, Annick, Weingart, Jon, Brem, Henry, Dolan, M. Eileen, Delaney, Shannon M., Vredenburgh, James, Rich, Jeremy, Friedman, Allan H., Reardon, David A., Sampson, John H., Pegg, Anthony E., Moschel, Robert C., Birch, Robert, McLendon, Roger E., Provenzale, James M., Gururangan, Sridharan, Dancey, Janet E., Maxwell, Jill, Tourt-Uhlig, Sandra, Herndon, James E., Bigner, Darell D., Friedman, Henry S.

Volltext

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma von QUINN, Jennifer A, REARDON, David A, AVGEROPOULOS, Nicholas, FINLAY, Jonathan, TOURT-UHLIG, Sandra, AFFRONTI, Mary Lou, EVANS, Brandon, STAFFORD-FOX, Valerie, ZAKNOEN, Sara, FRIEDMAN, Henry S, FRIEDMAN, Allan H, RICH, Jeremy N, SAMPSON, John H, PROVENZALE, James M, MCLENDON, Roger E, GURURANGAN, Sridharan, BIGNER, Darell D, HERNDON, James E

Volltext

Social Functioning and Facial Expression Recognition in Survivors of Pediatric Brain Tumors von Bonner, Melanie J., Hardy, Kristina K., Willard, Victoria W., Anthony, Kelly K., Hood, Maggie, Gururangan, Sridharan

Volltext

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma von Reardon, David A., Quinn, Jennifer A., Vredenburgh, James, Rich, Jeremy N., Gururangan, Sridharan, Badruddoja, Michael, Herndon, James E., Dowell, Jeannette M., Friedman, Allan H., Friedman, Henry S.

Volltext

High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor von JACKSON, Eric M, SHAIKH, Tamim H, GURURANGAN, Sridharan, JONES, Marilyn C, MALKIN, David, NIKKEL, Sarah M, ZUPPAN, Craig W, WAINWRIGHT, Luanne M, FAN ZHANG, BIEGEL, Jaclyn A

Volltext

PROGNOSTIC MARKER ANALYSIS IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS von McLendon, R. E., Lipp, E., Gururangan, S., Fuchs, H., Zagzag, D., Herndon, J., Healy, P.

Volltext

Phase II Trial of Carmustine Plus O 6 -Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma von Quinn, Jennifer A., Pluda, James, Dolan, M. Eileen, Delaney, Shannon, Kaplan, Richard, Rich, Jeremy N., Friedman, Allan H., Reardon, David A., Sampson, John H., Colvin, O. Michael, Haglund, Michael M., Pegg, Anthony E., Moschel, Robert C., McLendon, Roger E., Provenzale, James M., Gururangan, Sridharan, Tourt-Uhlig, Sandra, Herndon, James E., Bigner, Darell D., Friedman, Henry S.

Volltext